Cargando…
Comorbidity burden may explain adiponectin’s paradox as a marker of increased mortality risk in hemodialysis patients
Despite experimental evidence of beneficial metabolic, antiatherosclerotic and antiinflammatory effects of the 30 kDa adipokine, adiponectin, maintenance hemodialysis (MHD) patients with high adiponectin blood levels have paradoxically high mortality rates. We aimed to examine the direction of the a...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079690/ https://www.ncbi.nlm.nih.gov/pubmed/33907250 http://dx.doi.org/10.1038/s41598-021-88558-0 |